|
|
 |
|
Viewing report
|
|
|
|
Global Intravenous Immunoglobulin (IVIG) Market: An Analysis
Koncept Analytics, Jan 2011, Pages: 40
Intravenous Immunoglobulin (IVIG) has been the driving force of the growth of plasma products industry. The demand for IVIG has been growing on account of increased usage of IVIG in the treatment of primary immunodeficiency as well as newer neurological indications. Moreover, unmet medical needs in emerging markets like China and Japan are likely to propel the demand for IVIG in future. The IVIG use rates vary significantly from one country to another depending on reimbursement rates and clinical practices at hospitals. The IVIG usage was highest in the US in 2009 followed by Sweden, Austria and France.
Despite challenges like stringent regulations, ensuring adequate supply of human plasma and high cost of treatment, the global IVIG market is all set to witness high growth in the coming years as a result of growing ageing population, increasing number of patients with bleeding disorder and rising health expenditure.
The present report offers an analysis of the global IVIG market with a special focus on the IVIG markets of US, China and Korea. It also discusses key growth drivers and major challenges faced by IVIG industry. The report also profiles major players in the IVIG market.
Further, we have predicted the future growth of the IVIG market by combining SPSS’ data integration and analysis capabilities with our relevant findings. We employed various significant variables that have an impact on this industry and created regression models with SPSS to determine the future direction of the industry.
|
|
|
|
